Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Argus Health
Farmers Insurance
Johnson and Johnson
Cerilliant
Accenture
Cipla
AstraZeneca
Colorcon

Generated: August 20, 2017

DrugPatentWatch Database Preview

LOCORTEN Drug Profile

« Back to Dashboard

Which patents cover Locorten, and what generic Locorten alternatives are available?

Locorten is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in LOCORTEN is flumethasone pivalate. There are eleven drug master file entries for this compound. Additional details are available on the flumethasone pivalate profile page.

Summary for Tradename: LOCORTEN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list27
Patent Applications: see list1,213
Drug Prices:see details
DailyMed Link:LOCORTEN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
LOCORTEN
flumethasone pivalate
CREAM;TOPICAL016379-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LOCORTEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
LOCORTEN
flumethasone pivalate
CREAM;TOPICAL016379-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Accenture
Johnson and Johnson
McKinsey
Moodys
Cantor Fitzgerald
Baxter
Fuji
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot